Transcat, Inc. has executed an amendment to its $20 million secured revolving credit agreement, increasing the funds available under the amended credit facility to $30 million. The amended credit facility matures on September 20, 2018. Borrowings under the amended credit facility may be used for working capital and acquisitions. Borrowings available for acquisitions increased to $15 million in any fiscal year pursuant to the amended credit facility, compared with the $10 million available under the original credit facility.

Lee D. Rudow, President and CEO of Transcat, commented, "We have successfully and consistently grown over the last decade both organically and through acquisitions while maintaining a solid balance sheet. Our strong cash generation, combined with the expanded credit facility, provides us the financial flexibility to continue to advance our acquisition strategy. We believe our quality of service, differentiated processes and our strategic locations in the U.S. and Canada are leading competitive advantages in this market which should enable our continued growth."

Transcat, Inc. is a leading provider of accredited calibration and compliance services including analytical instrument qualifications, equipment and process validation.Targeted industries include life science, biotechnology, medical device, pharmaceutical and other FDA-regulated industries, industrial manufacturing, energy and utilities, chemical manufacturing and other industries. Throughout its 18 strategically located centers of excellence in the United States, Canada and Puerto Rico, Transcat delivers precise services with reliable turn-around times.

In addition, Transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation. Through its Distribution segment, Transcat markets and distributes premier and propriety brand instruments to nearly 15,000 customers. The Company offers access to more than 25,000 test, measurement and control products.